
AbCellera Biologics
Biotechnology company
Stránky společnostiRok založení
2012
Uzávěrka
2/10/2021
Ziskovost
125.8%
O společnosti
Total Funding
$371.2M
AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics
Number of employees
101-250
Headquarters
Vancouver, British Columbia, Canada